摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-[2-[2-[[(3S)-4-[3,5-dihydroxy-6-(hydroxymethyl)-4-[1-(1-hydroxy-3-oxopropan-2-yl)oxy-2-oxoethoxy]oxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-6-[2-[2-[3,5-dihydroxy-2-(hydroxymethyl)-6-methyloxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxyoxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-hydroxy-3-(1-hydroxy-3-oxopropan-2-yl)oxypropanal

中文名称
——
中文别名
——
英文名称
3-[2-[2-[[(3S)-4-[3,5-dihydroxy-6-(hydroxymethyl)-4-[1-(1-hydroxy-3-oxopropan-2-yl)oxy-2-oxoethoxy]oxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-6-[2-[2-[3,5-dihydroxy-2-(hydroxymethyl)-6-methyloxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxyoxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-hydroxy-3-(1-hydroxy-3-oxopropan-2-yl)oxypropanal
英文别名
——
3-[2-[2-[[(3S)-4-[3,5-dihydroxy-6-(hydroxymethyl)-4-[1-(1-hydroxy-3-oxopropan-2-yl)oxy-2-oxoethoxy]oxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-6-[2-[2-[3,5-dihydroxy-2-(hydroxymethyl)-6-methyloxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxyoxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-hydroxy-3-(1-hydroxy-3-oxopropan-2-yl)oxypropanal化学式
CAS
——
化学式
C54H88O44
mdl
——
分子量
1441.2
InChiKey
LCUAEVUSMJRKFI-LUXCPWJESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -14.5
  • 重原子数:
    98
  • 可旋转键数:
    34
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.93
  • 拓扑面积:
    691
  • 氢给体数:
    23
  • 氢受体数:
    44

文献信息

  • MODIFIED AND DERIVATIZED ß-GLUCAN COMPOUNDS, COMPOSITIONS, AND METHODS
    申请人:Biothera, Inc.
    公开号:US20140228543A1
    公开(公告)日:2014-08-14
    Modified and/or derivativized β-glucans with an enhanced capacity to modulate human immune response as compared to the parent, unmodified and/or underivatized β-glucans are demonstrated.
    改性和/或衍生的β-葡聚糖表现出比未改性和/或未衍生的β-葡聚糖更强的调节人类免疫反应的能力。
查看更多